Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
The Journal of Dermatology|May 5, 2020
Acquired agminated melanocytic nevus in the acral area is a potential mimicker of acral lentiginous melanoma: A three-case series report and published work reviewKohei Ogawa, Masakazu Fujimoto, Toshihiro Takai, et al.
Circulation|May 17, 2006
Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodelingJun Asai, Hideya Takenaka, Kengo F Kusano, et al.
Circulation|November 8, 2006
Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarctionHiromichi Hamada, Myeong Kon Kim, Atsushi Iwakura, et al.
Journal of Radiation Research|April 9, 2020
High dose rate interstitial brachytherapy for early stage lip cancer using customized dental spacerKoji Masui, Hideya Yamazaki, Gen Suzuki, et al.
Cancer Science|March 26, 2018
Podoplanin: An emerging cancer biomarker and therapeutic targetHarini Krishnan, Julie Rayes, Tomoyuki Miyashita, et al.
Oncology Letters|August 11, 2020
Safety and tolerability of PD-1/PD-L1 inhibitors in elderly and frail patients with advanced malignanciesTomoki Sakakida, Takeshi Ishikawa, Junji Uchino, et al.
The Journal of Dermatology|November 30, 2019
Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019Yasuhiro Nakamura, Jun Asai, Hiroshi Igaki, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2021
Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 casesYasuhiro Fujisawa, Takamichi Ito, Hiroshi Kato, et al.
The Journal of Investigative Dermatology|November 4, 2011
CXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic miceYukihide Nishimura, Masaaki Ii, Gangjian Qin, et al.
Oncology Letters|August 20, 2019
Clinical features of immune-related thyroid dysfunction and its association with outcomes in patients with advanced malignancies treated by PD-1 blockadeTomoki Sakakida, Takeshi Ishikawa, Junji Uchino, et al.
Pageof 9